1. Home
  2. AAPG vs NHI Comparison

AAPG vs NHI Comparison

Compare AAPG & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • NHI
  • Stock Information
  • Founded
  • AAPG 2009
  • NHI 1991
  • Country
  • AAPG China
  • NHI United States
  • Employees
  • AAPG N/A
  • NHI N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • NHI Real Estate Investment Trusts
  • Sector
  • AAPG Health Care
  • NHI Real Estate
  • Exchange
  • AAPG Nasdaq
  • NHI Nasdaq
  • Market Cap
  • AAPG 3.6B
  • NHI 3.7B
  • IPO Year
  • AAPG 2025
  • NHI 1991
  • Fundamental
  • Price
  • AAPG $31.73
  • NHI $76.80
  • Analyst Decision
  • AAPG Buy
  • NHI Buy
  • Analyst Count
  • AAPG 2
  • NHI 4
  • Target Price
  • AAPG $48.00
  • NHI $82.75
  • AVG Volume (30 Days)
  • AAPG 8.4K
  • NHI 210.3K
  • Earning Date
  • AAPG 11-19-2025
  • NHI 11-06-2025
  • Dividend Yield
  • AAPG N/A
  • NHI 4.79%
  • EPS Growth
  • AAPG N/A
  • NHI 8.88
  • EPS
  • AAPG N/A
  • NHI 3.17
  • Revenue
  • AAPG $54,524,554.00
  • NHI $357,572,000.00
  • Revenue This Year
  • AAPG N/A
  • NHI $4.68
  • Revenue Next Year
  • AAPG $368.64
  • NHI $10.60
  • P/E Ratio
  • AAPG N/A
  • NHI $24.24
  • Revenue Growth
  • AAPG N/A
  • NHI 8.40
  • 52 Week Low
  • AAPG $16.50
  • NHI $65.13
  • 52 Week High
  • AAPG $48.45
  • NHI $82.32
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 32.13
  • NHI 54.79
  • Support Level
  • AAPG $32.68
  • NHI $74.87
  • Resistance Level
  • AAPG $34.31
  • NHI $76.46
  • Average True Range (ATR)
  • AAPG 0.84
  • NHI 1.85
  • MACD
  • AAPG -0.08
  • NHI 0.24
  • Stochastic Oscillator
  • AAPG 8.71
  • NHI 73.25

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Share on Social Networks: